CARLSMED, INC.
For the period ended Jun 30, 2026. Filed Aug 5, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2026 · Filed Aug 5, 2026
CARL$14.52-5.2%Stored close · as of Nov 6, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
(in thousands)
| Six Months Ended June 30, | ||
|---|---|---|
| 2026 | 2025 | |
| Supplemental Disclosure of Noncash Investing and Financing Activities: | ||
| Right-of-use assets obtained in exchange for lease liabilities | $5,027 | $593 |
| Property and equipment obtained in exchange for lease liability | $270 | $— |
| Vesting of early exercised common stock options | $21 | $20 |
| Unpaid deferred offering and issuance costs | $144 | $1,190 |
| Capitalized internal use software included in accounts payable and accrued liabilities | $59 | $— |
| Cash, Cash Equivalents, and Restricted Cash Information: | ||
| Cash and cash equivalents, beginning of period | $85,793 | $40,125 |
| Restricted cash, beginning of period | 100 | 100 |
| Cash, cash equivalents, and restricted cash, beginning of period | 85,893 | 40,225 |
| Cash and cash equivalents, end of period | 46,244 | 33,472 |
| Restricted cash, end of period | 100 | 100 |
| Cash, cash equivalents, and restricted cash, end of period | $46,344 | $33,572 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.